Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 2/2004

01-04-2004

Membranous nephropathy after allogeneic stem cell transplantation: meport of 2 cases

Authors: Chizuko Tsutsumi, Yasushi Miyazaki, Takuya Fukushima, Shinichiro Yoshida, Jun Taguchi, Chie Miyake, Masanobu Miyazaki, Shigeru Kohno, Ttsuro Jinnai, Masao Tomonaga

Published in: International Journal of Hematology | Issue 2/2004

Login to get access
Metadata
Title
Membranous nephropathy after allogeneic stem cell transplantation: meport of 2 cases
Authors
Chizuko Tsutsumi
Yasushi Miyazaki
Takuya Fukushima
Shinichiro Yoshida
Jun Taguchi
Chie Miyake
Masanobu Miyazaki
Shigeru Kohno
Ttsuro Jinnai
Masao Tomonaga
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue 2/2004
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.03096

Other articles of this Issue 2/2004

International Journal of Hematology 2/2004 Go to the issue

Case Report

Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma: A Japan Clinical Oncology Group Study, JCOG 9301

Case Report

Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: A case report and review of the literature

Case Report

Bone marrow hypoplasia complicating tacrolimus (FK506) therapy

OriginalPaper

Progress in the understanding of protease-activated receptors

OriginalPaper

Spontaneous remission of epstein-barr virus-negative non-hodgkin’s lymphoma after withdrawal of cyclosporine in a patient with refractory anemia

Report

The fifth nagoya international blood and marrow transplantation symposium: unlimited possibilities of hematopoietic cell transplantation: lessons from the past and prospects for the future
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits